1. Home
  2. MPLT vs TPB Comparison

MPLT vs TPB Comparison

Compare MPLT & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$0.00

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Turning Point Brands Inc.

TPB

Turning Point Brands Inc.

HOLD

Current Price

$60.05

Market Cap

1.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPLT
TPB
Founded
2018
1988
Country
United States
United States
Employees
N/A
484
Industry
Biotechnology: Pharmaceutical Preparations
Tobacco
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2025
2015

Fundamental Metrics

Financial Performance
Metric
MPLT
TPB
Price
N/A
$60.05
Analyst Decision
Buy
Analyst Count
3
Target Price
N/A
$115.00
AVG Volume (30 Days)
N/A
304.3K
Earning Date
09-24-2026
05-07-2026
Dividend Yield
N/A
0.39%
EPS Growth
N/A
45.33
EPS
N/A
3.11
Revenue
N/A
$463,062,000.00
Revenue This Year
N/A
$13.68
Revenue Next Year
N/A
$11.32
P/E Ratio
N/A
$19.45
Revenue Growth
N/A
28.39
52 Week Low
N/A
$58.63
52 Week High
N/A
$146.90

Technical Indicators

Market Signals
Indicator
MPLT
TPB
Relative Strength Index (RSI) 31.34 19.52
Support Level $10.67 N/A
Resistance Level $20.20 $91.03
Average True Range (ATR) 0.79 2.51
MACD 0.08 -1.26
Stochastic Oscillator 16.14 10.39

Price Performance

Historical Comparison
MPLT
TPB

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

About TPB Turning Point Brands Inc.

Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum, including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments, namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.

Share on Social Networks: